ijBio 28.05.2020

ijBio 28.05.2020

Infojet Club

ijBio: Farm Involved ijBio-Index:

28.05.2020:

AstraZeneca (AZN) $53,5 (+1.96%)

Inovio (INO) $13,3 (+0.82%)

Moderna (MRNA) $55,5 (+6.5%)

Abbot (ABT) $92,2 (+1.5%)

Gilead (GILD). $75,3 (+0.6%)

Adaptive (ADPT) $38,9 (-0.4%)

CytoDyn (CYDY) $2,8 (-5%)

AbbVie (ABBV) $90 (0%)

Deciphera (DCPH) $57 (-2.80%)

Sorrento (SRNE) $4.9 (-4.26%)

---> next day

At close 28.05.20=483 (+0,83)

At close 27.05.20= 479 (-1,1%)

At close 26.05.20= 485 (-3,8%)

Index was launched 26.05.20 = 504

--

Merck, Pfizer share gains contribute to Dow's 86-point climb

France Paves Way to Reopen; English Soccer in June: Virus Update

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

Coronavirus update: U.S. marks grim milestone as Trump preps executive order on social-media companies

Moderna Stock Is Giving Investors a Wild Ride. Blame It on Shifting Covid-19 Vaccine News.

Ad Raging BullHow He Made $2.8M Trading Stocks Part-Time At Home

Dow up 200 points on gains in shares of Boeing, Pfizer

How Novavax is pulling out all the stops to produce a coronavirus vaccine by next year

Gilead study shows shorter 5-day course of remdesivir works as well as 10-day one

YouTube Virus Misinformation Fight Trips on Drug Touted by Trump

ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic'

Pfizer (PFE) Down 1.9% Since Last Earnings Report: Can It Rebound?

Zacks.com featured highlights include: TakeTwo Interactive Software, Gilead Sciences and Regeneron Pharmaceuticals

TradeZero America Co-founder on investor trends during market volatility

AstraZeneca says it may consider exposing vaccine trial participants to virus

Pfizer ties up with glass maker Corning for vial supply

Gilead Inks 10-Year Deal With Arcus for Immuno-oncology Drugs

Roche and Gilead Sciences Testing Two-Drug Covid-19 Combo

Gilead Is Creating A Coronavirus Drug Stockpile — Is Gilead Stock A Buy?

Dow climbs 69 points on gains in shares of Boeing, Merck

Ironwood to Halt MD-7246 Development After Study Failure

Don't Waste Your Money on Penny Stocks; These 3 Are Better Buys

Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Is ISRG Stock A Buy After Coronavirus Slammed Quarterly Growth?

Revoking Hong Kong’s special status is Trump’s ‘nuclear option’ that could trigger irrevocable U.S.-China split, analysts warn

Roche's shares rise on news of study testing Actemra, remdesivir in COVID-19 patients

A $39B Stock Fund Puts Dividends in Perspective During the Coronavirus Crisis

Is Johnson and Johnson Stock a Buy?

Coronavirus 2020: Where to Invest $500 Right Now

GSK targets production of 1bn doses of coronavirus vaccine booster

GSK aims for 1 billion doses with COVID vaccine booster plan

Moderna extends lipids deal to boost COVID-19 vaccine candidate output

With M&A Dead, Wall Street Bankers Keep Busy With Stock Sales

The lessons and consequences of a failed megadeal

U.S. FDA finds high levels of carcinogen in diabetes drug metformin

Top 1st-Quarter Buys of Steven Cohen's Firm

Abbott (ABT) Gains But Lags Market: What You Should Know

Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know

Gilead’s Remdesivir May Be a Coronavirus Silver Bullet — But It’s Already Baked in the Stock Price

Why Moderna Stock Dropped Today

Covid Report: Why Moderna's Vaccine Prodded A Mass Biotech Sell-Off


Инновационные тенденции.

Infojet Club

Report Page